-
WHO and the Global Fund to Fight AIDS, TB and Malaria said today that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least US$ 1.6 billion in international funding for treatment and prevention of the disease.
18 March 2013 | World Health Organization
-
The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.
18 March 2013 | Stop TB Partnership
-
The Ugandan government's draft 2013/2014 budget allocates US$38.5 million to enrol a further 100,000 people living with HIV on life-prolonging antiretroviral (ARV) drugs. But activists say the money, while welcome in a country still largely dependent on donor funds for its HIV programmes, is not sufficient to meet treatment needs.
15 March 2013 | IRIN Plus News
-
At the fifty-sixth session of the Commission on Narcotic Drugs, which is running from 11-15 March, drug use and HIV will be addressed through a number of channels, including a draft resolution calling for the intensification of efforts to reduce HIV to attain the targets of the 2011 Political Declaration on HIV and AIDS.
13 March 2013 | UNAIDS
-
1. The case of the Mississippi baby means we’re close to curing AIDS.
2. AIDS is the leading killer of babies worldwide.
3. Mothers with HIV should never breast-feed.
4. Drugs are the key to preventing HIV’s spread.
5. AIDS can’t be defeated.
12 March 2013 | Washington Post
-
The HIV/AIDS epidemic arrived in sub-Saharan Africa after decades of neglect had left healthcare systems dangerously weak, barely able to cope with the onslaught of patients. Then the money started pouring in. But the jury is still out on whether the large sums of AIDS funding have made healthcare systems more resilient.
08 March 2013 | IRIN
-
After reviewing and reforming its grant process, the Global Fund to Fight AIDS, Tuberculosis and Malaria is back in business, announcing the first handful of countries slated to receive up to US$1.9 billion in available funding over the next two years.
01 March 2013 | IRIN Plus News
-
Mirroring global carbon permit markets to mitigate climate change, we propose a cap-and-trade system consisting of a global cost-effectiveness criterion and a disability-adjusted life year (DALY) global credit market.
28 February 2013 | PLoS Medicine
-
Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives.
27 February 2013 | Eurekalert Inf Dis
-
In the first days of March, the governing body of UNITAID, the organisation financed mainly through a levy on air tickets, will decide on a new 4-year strategy. We believe UNITAID's new strategy should also include tackling a prevalent and serious, but curable, HIV co-morbidity: hepatitis C virus (HCV) infection.
23 February 2013 | The Lancet
Get set for HIV treatmentA tool to help you decide whether you are ready to start taking HIV treatment.
HIV, GPs & other primary careThis booklet explains the services GPs offer, how this fits with HIV specialist care, and how to make the most of primary care services.
Treatment as prevention – free webinar 20 March 2013As
part of its European HIV prevention work, NAM is collaborating...
Microbicides research – free webinar 22 February 2013As
part of its European HIV prevention work, NAM is collaborating...
HIV treatment update – Winter 2013 21 February 2013The new edition of HIV treatment update (HTU) is on...